Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • IR
    • IR News
    • Management
    • IR Library
    • Stock Information
    • Other Contents
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. 2024

2024

20241223

Congress CEO Keiichi Fukuda will present at the 9th Annual Symposium of the Center of Definitive and Curative Medicine at Stanford.

2024122

Congress Takehiko Kaneko, CMO of Heartseed, to Speak at the Global CVCT Forum

20241114

Media CEO Keiichi Fukuda Interviewed by BiotechTV

2024115

Seminar The speech given by CEO Keiichi Fukuda at the Nikkei Forum "Investing in Japanese Regenerative Medicine", held on September 17, 2024, has been posted on the NIKKEI ASIA website.

20241021

Congress Heartseed COO Kikuo Yasui is Speaking at the "2nd Cell & Gene Tech Investment Forum" in South Korea on October 25.

2024108

Media Heartseed was featured on CNN's "Tomorrow Transformed".

2024101

PR Notice Concerning Positive Recommendation from Safety Monitoring Committee for Continuing High-dose Arm in HS-001 Clinical Trial (LAPiS Study)

2024916

Seminar Heartseed CMO Takehiko Kaneko is Speaking at the "Global Innovations in Healthcare" Webinar

202493

Media An article by COO Kikuo Yasui on Japan's drug discovery ecosystem has been published in "BioSpectrum Asia".

202482

Media Heartseed was Featured on NHK World's "jib TV"

1 2 3

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
Seavans South Building 5F, 1-2-3 Shibaura, Minato-ku, Tokyo 105-0023, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • IR
  • Contacts

language

  • English
  • Japanese

GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED